APO Research
Talk to an analyst

APO RESEARCH · REPORT

SNP Microarray Testing and Analysis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global SNP Microarray Testing and Analysis Market Analysis and Forecast 2026-2032

28 December 2025205 pages

Choose your research edition.

Industry ResearchSNP Microarray Testing and Analysis Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal SNP Microarray Testing and Analysis Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal SNP Microarray Testing and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SNP Microarray Testing and Analysis Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal SNP Microarray Testing and Analysis Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global SNP Microarray Testing and Analysis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of SNP Microarray Testing and Analysis include Thermo Fisher Scientific, Illumina, Agilent, Roche, Bio-Rad, CD Genomics, Ambry Genetics, Labcorp and Allele Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for SNP Microarray Testing and Analysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of SNP Microarray Testing and Analysis, also provides the revenue of main regions and countries. Of the upcoming market potential for SNP Microarray Testing and Analysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the SNP Microarray Testing and Analysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global SNP Microarray Testing and Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for SNP Microarray Testing and Analysis revenue, projected growth trends, production technology, application and end-user industry.

SNP Microarray Testing and Analysis Segment by Company

Thermo Fisher Scientific

Illumina

Agilent

Roche

Bio-Rad

CD Genomics

Ambry Genetics

Labcorp

Allele Diagnostics

Sonic Genetics

Invitae

Genetics Generation Advancement (GGA)

Quest Diagnostics

CapitalBio

HNL Lab Medicine

Psomagen

VCGS

Genetics Associates

SNP Microarray Testing and Analysis Segment by Type

Whole Genome SNP Microarrays

Custom SNP Microarrays

SNP Microarray Testing and Analysis Segment by Application

Pharmaceuticals and Pharmacogenomics

Diagnostic Research

Agricultural Biotechnology

Other

SNP Microarray Testing and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SNP Microarray Testing and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SNP Microarray Testing and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SNP Microarray Testing and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of SNP Microarray Testing and Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of SNP Microarray Testing and Analysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SNP Microarray Testing and Analysis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global SNP Microarray Testing and Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Whole Genome SNP Microarrays Major Player Table 3. Custom SNP Microarrays Major Player Table 4. Global SNP Microarray Testing and Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceuticals and Pharmacogenomics Major Player Table 6. Diagnostic Research Major Player Table 7. Agricultural Biotechnology Major Player Table 8. Other Major Player Table 9. SNP Microarray Testing and Analysis Industry Trends Table 10. SNP Microarray Testing and Analysis Industry Drivers Table 11. SNP Microarray Testing and Analysis Industry Opportunities and Challenges Table 12. SNP Microarray Testing and Analysis Industry Restraints Table 13. Global SNP Microarray Testing and Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global SNP Microarray Testing and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 15. Global SNP Microarray Testing and Analysis Market Share by Region (2021-2026) Table 16. Global SNP Microarray Testing and Analysis Market Size by Region (2027-2032) & (US$ Million) Table 17. Global SNP Microarray Testing and Analysis Market Share by Region (2027-2032) Table 18. Global SNP Microarray Testing and Analysis Revenue by Players (US$ Million) & (2021-2026) Table 19. Global SNP Microarray Testing and Analysis Revenue Market Share by Players (2021-2026) Table 20. Global SNP Microarray Testing and Analysis Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global SNP Microarray Testing and Analysis Key Players Headquarters & Area Served Table 22. Global SNP Microarray Testing and Analysis Players, Product Type & Application Table 23. Global SNP Microarray Testing and Analysis Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global SNP Microarray Testing and Analysis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global SNP Microarray Testing and Analysis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global SNP Microarray Testing and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 28. Global SNP Microarray Testing and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 29. Global SNP Microarray Testing and Analysis Revenue Market Share by Type (2021-2026) Table 30. Global SNP Microarray Testing and Analysis Revenue Market Share by Type (2027-2032) Table 31. Global SNP Microarray Testing and Analysis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global SNP Microarray Testing and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 33. Global SNP Microarray Testing and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 34. Global SNP Microarray Testing and Analysis Revenue Market Share by Application (2021-2026) Table 35. Global SNP Microarray Testing and Analysis Revenue Market Share by Application (2027-2032) Table 36. Thermo Fisher Scientific Company Information Table 37. Thermo Fisher Scientific Business Overview Table 38. Thermo Fisher Scientific SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Thermo Fisher Scientific SNP Microarray Testing and Analysis Product Portfolio Table 40. Thermo Fisher Scientific Recent Development Table 41. Illumina Company Information Table 42. Illumina Business Overview Table 43. Illumina SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Illumina SNP Microarray Testing and Analysis Product Portfolio Table 45. Illumina Recent Development Table 46. Agilent Company Information Table 47. Agilent Business Overview Table 48. Agilent SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Agilent SNP Microarray Testing and Analysis Product Portfolio Table 50. Agilent Recent Development Table 51. Roche Company Information Table 52. Roche Business Overview Table 53. Roche SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Roche SNP Microarray Testing and Analysis Product Portfolio Table 55. Roche Recent Development Table 56. Bio-Rad Company Information Table 57. Bio-Rad Business Overview Table 58. Bio-Rad SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Bio-Rad SNP Microarray Testing and Analysis Product Portfolio Table 60. Bio-Rad Recent Development Table 61. CD Genomics Company Information Table 62. CD Genomics Business Overview Table 63. CD Genomics SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. CD Genomics SNP Microarray Testing and Analysis Product Portfolio Table 65. CD Genomics Recent Development Table 66. Ambry Genetics Company Information Table 67. Ambry Genetics Business Overview Table 68. Ambry Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Ambry Genetics SNP Microarray Testing and Analysis Product Portfolio Table 70. Ambry Genetics Recent Development Table 71. Labcorp Company Information Table 72. Labcorp Business Overview Table 73. Labcorp SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Labcorp SNP Microarray Testing and Analysis Product Portfolio Table 75. Labcorp Recent Development Table 76. Allele Diagnostics Company Information Table 77. Allele Diagnostics Business Overview Table 78. Allele Diagnostics SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Allele Diagnostics SNP Microarray Testing and Analysis Product Portfolio Table 80. Allele Diagnostics Recent Development Table 81. Sonic Genetics Company Information Table 82. Sonic Genetics Business Overview Table 83. Sonic Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Sonic Genetics SNP Microarray Testing and Analysis Product Portfolio Table 85. Sonic Genetics Recent Development Table 86. Invitae Company Information Table 87. Invitae Business Overview Table 88. Invitae SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Invitae SNP Microarray Testing and Analysis Product Portfolio Table 90. Invitae Recent Development Table 91. Genetics Generation Advancement (GGA) Company Information Table 92. Genetics Generation Advancement (GGA) Business Overview Table 93. Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Product Portfolio Table 95. Genetics Generation Advancement (GGA) Recent Development Table 96. Quest Diagnostics Company Information Table 97. Quest Diagnostics Business Overview Table 98. Quest Diagnostics SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Quest Diagnostics SNP Microarray Testing and Analysis Product Portfolio Table 100. Quest Diagnostics Recent Development Table 101. CapitalBio Company Information Table 102. CapitalBio Business Overview Table 103. CapitalBio SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CapitalBio SNP Microarray Testing and Analysis Product Portfolio Table 105. CapitalBio Recent Development Table 106. HNL Lab Medicine Company Information Table 107. HNL Lab Medicine Business Overview Table 108. HNL Lab Medicine SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. HNL Lab Medicine SNP Microarray Testing and Analysis Product Portfolio Table 110. HNL Lab Medicine Recent Development Table 111. Psomagen Company Information Table 112. Psomagen Business Overview Table 113. Psomagen SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Psomagen SNP Microarray Testing and Analysis Product Portfolio Table 115. Psomagen Recent Development Table 116. VCGS Company Information Table 117. VCGS Business Overview Table 118. VCGS SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. VCGS SNP Microarray Testing and Analysis Product Portfolio Table 120. VCGS Recent Development Table 121. Genetics Associates Company Information Table 122. Genetics Associates Business Overview Table 123. Genetics Associates SNP Microarray Testing and Analysis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Genetics Associates SNP Microarray Testing and Analysis Product Portfolio Table 125. Genetics Associates Recent Development Table 126. North America SNP Microarray Testing and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 127. North America SNP Microarray Testing and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 128. North America SNP Microarray Testing and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 129. North America SNP Microarray Testing and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 130. North America SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America SNP Microarray Testing and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 132. North America SNP Microarray Testing and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 133. Europe SNP Microarray Testing and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe SNP Microarray Testing and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe SNP Microarray Testing and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe SNP Microarray Testing and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe SNP Microarray Testing and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 139. Europe SNP Microarray Testing and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 140. China SNP Microarray Testing and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 141. China SNP Microarray Testing and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 142. China SNP Microarray Testing and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 143. China SNP Microarray Testing and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia SNP Microarray Testing and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia SNP Microarray Testing and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia SNP Microarray Testing and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 147. Asia SNP Microarray Testing and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia SNP Microarray Testing and Analysis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia SNP Microarray Testing and Analysis Revenue by Region (US$ Million) & (2021-2026) Table 150. Asia SNP Microarray Testing and Analysis Revenue by Region (US$ Million) & (2027-2032) Table 151. SAMEA SNP Microarray Testing and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 152. SAMEA SNP Microarray Testing and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 153. SAMEA SNP Microarray Testing and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 154. SAMEA SNP Microarray Testing and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 155. SAMEA SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. SAMEA SNP Microarray Testing and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 157. SAMEA SNP Microarray Testing and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. SNP Microarray Testing and Analysis Image Figure 2. Global SNP Microarray Testing and Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SNP Microarray Testing and Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Whole Genome SNP Microarrays Image Figure 5. Custom SNP Microarrays Image Figure 6. Global SNP Microarray Testing and Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global SNP Microarray Testing and Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceuticals and Pharmacogenomics Image Figure 9. Diagnostic Research Image Figure 10. Agricultural Biotechnology Image Figure 11. Other Image Figure 12. Global SNP Microarray Testing and Analysis Market Size (US$ Million) & (2021-2032) Figure 13. Global SNP Microarray Testing and Analysis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global SNP Microarray Testing and Analysis Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global SNP Microarray Testing and Analysis Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global SNP Microarray Testing and Analysis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global SNP Microarray Testing and Analysis Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global SNP Microarray Testing and Analysis Revenue Market Share by Type (2021-2032) Figure 20. Global SNP Microarray Testing and Analysis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global SNP Microarray Testing and Analysis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global SNP Microarray Testing and Analysis Revenue Market Share by Application (2021-2032) Figure 23. North America SNP Microarray Testing and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032) Figure 25. North America SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032) Figure 26. North America SNP Microarray Testing and Analysis Revenue Share by Country (2021-2032) Figure 27. United States SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe SNP Microarray Testing and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032) Figure 32. Europe SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032) Figure 33. Europe SNP Microarray Testing and Analysis Revenue Share by Country (2021-2032) Figure 34. Germany SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China SNP Microarray Testing and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032) Figure 44. China SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032) Figure 45. Asia SNP Microarray Testing and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032) Figure 47. Asia SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032) Figure 48. Asia SNP Microarray Testing and Analysis Revenue Share by Region (2021-2032) Figure 49. Japan SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA SNP Microarray Testing and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032) Figure 57. SAMEA SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032) Figure 58. SAMEA SNP Microarray Testing and Analysis Revenue Share by Country (2021-2032) Figure 59. Brazil SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt SNP Microarray Testing and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Genome SNP Microarrays
  • Custom SNP Microarrays
Applications
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Illumina
  • Agilent
  • Roche
  • Bio-Rad
  • CD Genomics
  • Ambry Genetics
  • Labcorp
  • Allele Diagnostics
  • Sonic Genetics
  • Invitae
  • Genetics Generation Advancement (GGA)
  • Quest Diagnostics
  • CapitalBio
  • HNL Lab Medicine
  • Psomagen
  • VCGS
  • Genetics Associates

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 SNP Microarray Testing and Analysis Market by Type
  3. 1.2.1 Global SNP Microarray Testing and Analysis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Whole Genome SNP Microarrays
  5. 1.2.3 Custom SNP Microarrays
  6. 1.3 SNP Microarray Testing and Analysis Market by Application
  7. 1.3.1 Global SNP Microarray Testing and Analysis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceuticals and Pharmacogenomics
  9. 1.3.3 Diagnostic Research
  10. 1.3.4 Agricultural Biotechnology
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 SNP Microarray Testing and Analysis Market Dynamics
  1. 2.1 SNP Microarray Testing and Analysis Industry Trends
  2. 2.2 SNP Microarray Testing and Analysis Industry Drivers
  3. 2.3 SNP Microarray Testing and Analysis Industry Opportunities and Challenges
  4. 2.4 SNP Microarray Testing and Analysis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global SNP Microarray Testing and Analysis Market Perspective (2021-2032)
  2. 3.2 Global SNP Microarray Testing and Analysis Growth Trends by Region
  3. 3.2.1 Global SNP Microarray Testing and Analysis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global SNP Microarray Testing and Analysis Market Size by Region (2021-2026)
  5. 3.2.3 Global SNP Microarray Testing and Analysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global SNP Microarray Testing and Analysis Revenue by Players
  2. 4.1.1 Global SNP Microarray Testing and Analysis Revenue by Players (2021-2026)
  3. 4.1.2 Global SNP Microarray Testing and Analysis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global SNP Microarray Testing and Analysis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global SNP Microarray Testing and Analysis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global SNP Microarray Testing and Analysis Key Players Headquarters & Area Served
  7. 4.4 Global SNP Microarray Testing and Analysis Players, Product Type & Application
  8. 4.5 Global SNP Microarray Testing and Analysis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global SNP Microarray Testing and Analysis Market CR5 and HHI
  11. 4.6.3 2025 SNP Microarray Testing and Analysis Tier 1, Tier 2, and Tier 3
5 SNP Microarray Testing and Analysis Market Size by Type
  1. 5.1 Global SNP Microarray Testing and Analysis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
  3. 5.3 Global SNP Microarray Testing and Analysis Revenue Market Share by Type (2021-2032)
6 SNP Microarray Testing and Analysis Market Size by Application
  1. 6.1 Global SNP Microarray Testing and Analysis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
  3. 6.3 Global SNP Microarray Testing and Analysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific SNP Microarray Testing and Analysis Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Illumina
  8. 7.2.1 Illumina Company Information
  9. 7.2.2 Illumina Business Overview
  10. 7.2.3 Illumina SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Illumina SNP Microarray Testing and Analysis Product Portfolio
  12. 7.2.5 Illumina Recent Developments
  13. 7.3 Agilent
  14. 7.3.1 Agilent Company Information
  15. 7.3.2 Agilent Business Overview
  16. 7.3.3 Agilent SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent SNP Microarray Testing and Analysis Product Portfolio
  18. 7.3.5 Agilent Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Roche SNP Microarray Testing and Analysis Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Bio-Rad
  26. 7.5.1 Bio-Rad Company Information
  27. 7.5.2 Bio-Rad Business Overview
  28. 7.5.3 Bio-Rad SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Rad SNP Microarray Testing and Analysis Product Portfolio
  30. 7.5.5 Bio-Rad Recent Developments
  31. 7.6 CD Genomics
  32. 7.6.1 CD Genomics Company Information
  33. 7.6.2 CD Genomics Business Overview
  34. 7.6.3 CD Genomics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CD Genomics SNP Microarray Testing and Analysis Product Portfolio
  36. 7.6.5 CD Genomics Recent Developments
  37. 7.7 Ambry Genetics
  38. 7.7.1 Ambry Genetics Company Information
  39. 7.7.2 Ambry Genetics Business Overview
  40. 7.7.3 Ambry Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ambry Genetics SNP Microarray Testing and Analysis Product Portfolio
  42. 7.7.5 Ambry Genetics Recent Developments
  43. 7.8 Labcorp
  44. 7.8.1 Labcorp Company Information
  45. 7.8.2 Labcorp Business Overview
  46. 7.8.3 Labcorp SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Labcorp SNP Microarray Testing and Analysis Product Portfolio
  48. 7.8.5 Labcorp Recent Developments
  49. 7.9 Allele Diagnostics
  50. 7.9.1 Allele Diagnostics Company Information
  51. 7.9.2 Allele Diagnostics Business Overview
  52. 7.9.3 Allele Diagnostics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Allele Diagnostics SNP Microarray Testing and Analysis Product Portfolio
  54. 7.9.5 Allele Diagnostics Recent Developments
  55. 7.10 Sonic Genetics
  56. 7.10.1 Sonic Genetics Company Information
  57. 7.10.2 Sonic Genetics Business Overview
  58. 7.10.3 Sonic Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sonic Genetics SNP Microarray Testing and Analysis Product Portfolio
  60. 7.10.5 Sonic Genetics Recent Developments
  61. 7.11 Invitae
  62. 7.11.1 Invitae Company Information
  63. 7.11.2 Invitae Business Overview
  64. 7.11.3 Invitae SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Invitae SNP Microarray Testing and Analysis Product Portfolio
  66. 7.11.5 Invitae Recent Developments
  67. 7.12 Genetics Generation Advancement (GGA)
  68. 7.12.1 Genetics Generation Advancement (GGA) Company Information
  69. 7.12.2 Genetics Generation Advancement (GGA) Business Overview
  70. 7.12.3 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Product Portfolio
  72. 7.12.5 Genetics Generation Advancement (GGA) Recent Developments
  73. 7.13 Quest Diagnostics
  74. 7.13.1 Quest Diagnostics Company Information
  75. 7.13.2 Quest Diagnostics Business Overview
  76. 7.13.3 Quest Diagnostics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Quest Diagnostics SNP Microarray Testing and Analysis Product Portfolio
  78. 7.13.5 Quest Diagnostics Recent Developments
  79. 7.14 CapitalBio
  80. 7.14.1 CapitalBio Company Information
  81. 7.14.2 CapitalBio Business Overview
  82. 7.14.3 CapitalBio SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CapitalBio SNP Microarray Testing and Analysis Product Portfolio
  84. 7.14.5 CapitalBio Recent Developments
  85. 7.15 HNL Lab Medicine
  86. 7.15.1 HNL Lab Medicine Company Information
  87. 7.15.2 HNL Lab Medicine Business Overview
  88. 7.15.3 HNL Lab Medicine SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 HNL Lab Medicine SNP Microarray Testing and Analysis Product Portfolio
  90. 7.15.5 HNL Lab Medicine Recent Developments
  91. 7.16 Psomagen
  92. 7.16.1 Psomagen Company Information
  93. 7.16.2 Psomagen Business Overview
  94. 7.16.3 Psomagen SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Psomagen SNP Microarray Testing and Analysis Product Portfolio
  96. 7.16.5 Psomagen Recent Developments
  97. 7.17 VCGS
  98. 7.17.1 VCGS Company Information
  99. 7.17.2 VCGS Business Overview
  100. 7.17.3 VCGS SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  101. 7.17.4 VCGS SNP Microarray Testing and Analysis Product Portfolio
  102. 7.17.5 VCGS Recent Developments
  103. 7.18 Genetics Associates
  104. 7.18.1 Genetics Associates Company Information
  105. 7.18.2 Genetics Associates Business Overview
  106. 7.18.3 Genetics Associates SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Genetics Associates SNP Microarray Testing and Analysis Product Portfolio
  108. 7.18.5 Genetics Associates Recent Developments
8 North America
  1. 8.1 North America SNP Microarray Testing and Analysis Revenue (2021-2032)
  2. 8.2 North America SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
  3. 8.2.1 North America SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
  4. 8.2.2 North America SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
  5. 8.3 North America SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
  6. 8.4 North America SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
  7. 8.4.1 North America SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
  8. 8.4.2 North America SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
  9. 8.5 North America SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
  10. 8.6 North America SNP Microarray Testing and Analysis Revenue by Country
  11. 8.6.1 North America SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
  13. 8.6.3 North America SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe SNP Microarray Testing and Analysis Revenue (2021-2032)
  2. 9.2 Europe SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
  3. 9.2.1 Europe SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
  4. 9.2.2 Europe SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
  5. 9.3 Europe SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
  6. 9.4 Europe SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
  7. 9.4.1 Europe SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
  8. 9.4.2 Europe SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
  9. 9.5 Europe SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
  10. 9.6 Europe SNP Microarray Testing and Analysis Revenue by Country
  11. 9.6.1 Europe SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
  13. 9.6.3 Europe SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China SNP Microarray Testing and Analysis Revenue (2021-2032)
  2. 10.2 China SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
  3. 10.2.1 China SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
  4. 10.2.2 China SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
  5. 10.3 China SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
  6. 10.4 China SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
  7. 10.4.1 China SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
  8. 10.4.2 China SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
  9. 10.5 China SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia SNP Microarray Testing and Analysis Revenue (2021-2032)
  2. 11.2 Asia SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
  3. 11.2.1 Asia SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
  4. 11.2.2 Asia SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
  5. 11.3 Asia SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
  6. 11.4 Asia SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
  7. 11.4.1 Asia SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
  8. 11.4.2 Asia SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
  9. 11.5 Asia SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
  10. 11.6 Asia SNP Microarray Testing and Analysis Revenue by Country
  11. 11.6.1 Asia SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
  13. 11.6.3 Asia SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA SNP Microarray Testing and Analysis Revenue (2021-2032)
  2. 12.2 SAMEA SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
  5. 12.3 SAMEA SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
  9. 12.5 SAMEA SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA SNP Microarray Testing and Analysis Revenue by Country
  11. 12.6.1 SAMEA SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst